ES2137190T3 - Linea de celulas continua y vacuna contra los coccidios aviarios. - Google Patents

Linea de celulas continua y vacuna contra los coccidios aviarios.

Info

Publication number
ES2137190T3
ES2137190T3 ES92915741T ES92915741T ES2137190T3 ES 2137190 T3 ES2137190 T3 ES 2137190T3 ES 92915741 T ES92915741 T ES 92915741T ES 92915741 T ES92915741 T ES 92915741T ES 2137190 T3 ES2137190 T3 ES 2137190T3
Authority
ES
Spain
Prior art keywords
coccidia
cell line
aviary
vaccine against
continuous cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92915741T
Other languages
English (en)
Inventor
Robert A Clare
Patricia Lufburrow
Timothy J Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2137190T3 publication Critical patent/ES2137190T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UNA LINEA DE CELULAS CONTINUA NO LINFOIDE ADAPTADA PARA LA PROPAGACION DE AVIAN COCCIDIA. ESTA LINEA DE CELULAS ES UTIL PARA LA PRODUCCION DE ANTIGENOS DE VACUNA PARA EL TRATAMIENTO PROFILACTICO DE AVES DE CORRAL, PARTICULARMENTE EN UNA NUEVA VACUNA PARA COCCIDIA.
ES92915741T 1991-07-12 1992-07-10 Linea de celulas continua y vacuna contra los coccidios aviarios. Expired - Lifetime ES2137190T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72925691A 1991-07-12 1991-07-12

Publications (1)

Publication Number Publication Date
ES2137190T3 true ES2137190T3 (es) 1999-12-16

Family

ID=24930240

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92915741T Expired - Lifetime ES2137190T3 (es) 1991-07-12 1992-07-10 Linea de celulas continua y vacuna contra los coccidios aviarios.

Country Status (10)

Country Link
US (2) US5674484A (es)
EP (1) EP0594743B1 (es)
JP (1) JP3129441B2 (es)
AT (1) ATE184912T1 (es)
CA (1) CA2112811C (es)
DE (1) DE69230037T2 (es)
DK (1) DK0594743T3 (es)
ES (1) ES2137190T3 (es)
GR (1) GR3032204T3 (es)
WO (1) WO1993001276A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500438B2 (en) 1995-06-07 2002-12-31 Pfizer Incorporated In ovo vaccination against coccidiosis
WO1996040233A1 (en) 1995-06-07 1996-12-19 Pfizer Inc. In ovo vaccination against coccidiosis
CA2213385A1 (en) * 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
US6605460B1 (en) 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine
JP4104548B2 (ja) 2001-08-30 2008-06-18 エンブレクス，インコーポレイテッド 接合子嚢を生成するための改良方法
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
AU2003231818B2 (en) 2002-05-21 2007-04-19 Intervet International B.V. Methods for the in vitro culture of Sporozoea sp. and user thereof
PL229487B1 (pl) 2002-11-12 2018-07-31 Brigham & Womens Hospital Inc Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
US6908620B2 (en) * 2002-12-09 2005-06-21 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine
ATE471155T1 (de) 2004-03-12 2010-07-15 Univ Georgia Neues impfstoffadjuvans und dessen herstellung und verwendung
ES2415358T3 (es) 2004-04-21 2013-07-25 The Brigham And Women's Hospital, Inc. Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/DPNAG) y procedimientos para el uso de los mismos
US7897150B1 (en) * 2007-04-09 2011-03-01 The Ohio State University Canine lymphoma cell line and uses thereof
CN102159540B (zh) 2008-07-21 2015-08-12 布赖汉姆妇女医院 与合成的β-1,6葡糖胺寡糖相关的方法和组合物
MX2011007732A (es) * 2009-01-22 2011-11-04 Univ Georgia Formulacion de mycoplasma gallisepticum.
AU2019301657B2 (en) * 2018-07-10 2026-02-05 Targan, Inc. Systems and methods of preparing and delivering gels
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
US4710377A (en) 1983-08-19 1987-12-01 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
US4650676A (en) * 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4874705A (en) * 1985-05-16 1989-10-17 Solvay & Cie, S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
ATE157545T1 (de) * 1985-12-03 1997-09-15 Dimminaco Ag Sa Ltd Antigene proteine und diese enthaltende impfstoffe zur verhütung von kokzidiose
US5028694A (en) * 1985-12-03 1991-07-02 Solvay & Cie, S.A. Antigenic proteins and vaccines containing them for prevention of coccidiosis caused by eimeria Eimeria necatrix and Eimeria tenella
US4753798A (en) * 1986-06-30 1988-06-28 American Cyanamid Company Methods and compositions for controlling protozoal infections in warm-blooded animals
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
NZ232372A (en) * 1989-02-10 1993-04-28 Merck & Co Inc Glycolipid-linked membrane-associated immunogens of eimeria useful in immunising poultry against coccidiosis
DK0575317T3 (da) * 1991-03-14 1996-12-09 British Tech Group Usa Rekombinant anticoccidie-vaccine
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines

Also Published As

Publication number Publication date
US5674484A (en) 1997-10-07
CA2112811A1 (en) 1993-01-21
GR3032204T3 (en) 2000-04-27
DE69230037T2 (de) 2000-01-05
DE69230037D1 (de) 1999-10-28
EP0594743A1 (en) 1994-05-04
ATE184912T1 (de) 1999-10-15
WO1993001276A1 (en) 1993-01-21
CA2112811C (en) 2004-01-13
EP0594743A4 (en) 1995-01-25
EP0594743B1 (en) 1999-09-22
JPH07505041A (ja) 1995-06-08
US5846527A (en) 1998-12-08
DK0594743T3 (da) 1999-12-20
JP3129441B2 (ja) 2001-01-29

Similar Documents

Publication Publication Date Title
ES2137190T3 (es) Linea de celulas continua y vacuna contra los coccidios aviarios.
ES2129423T3 (es) Vacunas.
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
ES2170096T3 (es) Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
DE69940975D1 (de) Verwendung von glp-1 oder analoge zur behandlung von schlaganfall
ATE288232T1 (de) Stent
ES2163504T3 (es) Formas de dosificacion de liberacion controlada de azitromicina.
ES2064121T3 (es) Agente para reducir o eliminar el crecimiento de los pelos del cuerpo humano.
MX9703694A (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
ES2091938T3 (es) Canula.
DE3784199D1 (de) Titanocene und deren verwendung.
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ES2007720A6 (es) Procedimiento de obtencion de una vacuna a base de flagelo bacterial.
DE3685282D1 (de) Rhombohedrisches polykristallines bornitrid und dessen herstellung.
DK585886A (da) Immunstimulerende middel og anvendelse deraf
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
AR044235A2 (es) Uso de una composicion que comprende merozoitos de eimeria vivos
ES2036809T3 (es) Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
IT1212847B (it) Protesi peniena semirigida per il trattamento dell'impotenza nella erezione maschile.
PT86314A (de) Zytostatisch wirksame anthracyclinderivate
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
ES2101317T3 (es) Medicamento para aumentar el nivel de testosterona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 594743

Country of ref document: ES